HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSIS

The Lancet

Volumn 327, Issue 8491, 1986, Pages 1211-1212

  Hauglustaine, D ^a   Waer, M ^a   Michielsen, P ^a   Goebels, J ^b   Vandeputte, M ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; DIALYSIS MEMBRANE; ETIOLOGY; HEMODIALYSIS; HUMAN; KIDNEY; LETTER; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; THERAPY;

ACRYLIC RESINS; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; CELLULOSE; HUMANS; KIDNEY, ARTIFICIAL;

EID: 0022569245     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(86)91189-X     Document Type: Letter

References (10)

1. Synovial amyloidosis in patients undergoing long-term haemodialysis
2. Pathologic fractures associated with idiopathic amyloidosis of bone in chronic haemodialysis patients
3. 2-microglobulin
4. 2-microglobulin
5. Beta-2 microglobulin is an amyloidogenic protein in man
6. 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis
7. Capsular synovial and bone amyloidosis: complications of long-term haemodialysis
8. 2-microglobulin in patients on maintenance haemodialysis. The effect of dialysis membrane
9. 2-microglobulin in haemodialyzed patients
10. Elimination of low molecular weight proteins during haemofiltration